升主动脉原发腔内修复的系统综述
该系统综述检索MEDLINE 1995年至2017年文献,纳入46篇仅针对升主动脉原发腔内修复的研究,共118例患者使用13种支架移植物。最常见为胸主动脉支架(84例,71.2%),主要治疗A型主动脉夹层(59例,50%);I型内漏率18.6%,再干预率9.3%,全因死亡率15.2%,主动脉相关死亡率5%。
要点
- 升主动脉腔内修复缺乏专用支架,胸主动脉支架为最常用类型(71.2%)。
- A型主动脉夹层是最常见治疗疾病(50%),其次为假性动脉瘤(29.7%)。
- I型内漏率18.6%,再干预率9.3%,需严格选择高外科风险患者。
核心结论
- 尽管无专用升主动脉支架,多种腔内技术已成功用于治疗不同升主动脉疾病。
- 患者选择至关重要,需使主动脉解剖与有限支架尺寸匹配,并限于高外科风险患者。
研究设计与样本
- 系统综述,检索MEDLINE数据库1995年1月1日至2017年1月31日,检索词为「ascending aortic stent」。
- 纳入仅以升主动脉为原发治疗部位的腔内支架研究,排除杂交弓部手术及升主动脉外科置换联合支架研究。
- 共纳入46篇文献,涉及118例患者,使用13种不同设计的主动脉支架移植物。
主要发现
- 最常用装置为胸主动脉支架(84例,71.2%),其次为腹主动脉 cuff(13例,11%)和定制移植物(12例,10.2%)。
- 最常见疾病为A型主动脉夹层(59例,50%),其次为主动脉假性动脉瘤(35例,29.7%)、动脉瘤(6例,5.1%)、穿透性动脉粥样硬化溃疡(5例,4.2%)和急性主动脉破裂(3例,2.5%)。
- 股动脉入路占62.7%(74例),经心尖17例(14.4%)、颈动脉15例(12.7%)、腋动脉8例(6.8%)。
- 总体I型内漏率18.6%(22例),11例(9.3%)需再干预;全因死亡率15.2%(18例),中转开放手术3.4%(4例),脑血管并发症3.4%(4例)。
- 主动脉相关死亡率5%(6例),平均随访17.2个月。
临床怎么用
- 升主动脉腔内修复应限于高外科风险患者,并需根据有限支架尺寸选择解剖匹配的患者。
- 胸主动脉支架是当前最常用的升主动脉腔内修复装置,但需警惕I型内漏和再干预风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular repair of the ascending aorta is currently limited to patients at high surgical risk with aortic diseases originating above the sinotubular junction. A number of different endovascular technologies and approaches have been used, although no consensus exists regarding a standardized technique. To better understand real-world endovascular approaches to the ascending aorta, we performed a comprehensive review of the types of endovascular aortic stents and associated vascular access used in repair of the ascending aorta. METHODS: A search of the MEDLINE database was conducted from January 1, 1995, through January 31, 2017, with the search term "ascending aortic stent." Studies involving endovascular stenting in which the primary therapy was confined exclusively to the ascending aorta were included. Studies involving hybrid arch procedures and surgical replacement of the ascending aorta associated with aortic stenting were excluded. The type of aortic stent, underlying aortic disease, and surgical approach were recorded along with outcomes, need for reinterventions, and follow-up. RESULTS: A total of 46 publications that focused on primary endovascular repair of the ascending aorta were identified. Thirteen different aortic stent grafts of various designs were used in 118 total patients. The most commonly used device types were thoracic stents (n = 84 [71.2%]) along with abdominal cuffs (n = 13 [11%]) and custom-made grafts (n = 12 [10.2%]). The most commonly treated aortic disease was type A aortic dissection (n = 59 [50%]), followed by aortic pseudoaneurysm (n = 35 [29.7%]), aortic aneurysm (n = 6 [5.1%]), penetrating atherosclerotic ulcer (n = 5 [4.2%]), and acute aortic rupture (n = 3 [2.5%]). Femoral arterial access was used in 62.7% of patients (n = 74); transapical (n = 17 [14.4%]), carotid (n = 15 [12.7%]), and axillary (n = 8 [6.8%]) approaches were also used. The overall type I endoleak rate was 18.6% (n = 22), with 11 patients (9.3%) requiring reintervention. Other complications included all-cause mortality (n = 18 [15.2%]), conversions to open surgery (n = 4 [3.4%]), and cerebrovascular complications (n = 4 [3.4%]). Aorta-related mortality was 5% (n = 6), and average follow-up was 17.2 months. CONCLUSIONS: Despite the absence of a dedicated aortic stent graft for the ascending aorta, patients with a range of ascending aortic diseases are being successfully treated by endovascular technologies. For optimal outcomes, patient selection is critical to align aortic anatomy with the limited device sizing options, and it should be reserved for patients at high surgical risk.
引用
- Muetterties CE, Menon R, Wheatley GH, et al. A systematic review of primary endovascular repair of the ascending aorta. J Vasc Surg. 2017. PMID: 28844469. doi:10.1016/j.jvs.2017.06.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。